in addition, other mechanisms/organs are involved, augmenting the pathological pathways: adipocytes (altered fat metabolism
due to insulin resistance), gastrointestinal tract (incretin deficiency and/or resistance), pancreatic α-cells (hyperglucagonemia
and increased hepatic sensitivity to glucagon), kidneys (enhanced glucose reabsorption), and central nervous system (insulin
resistance)